Starter badań:

Skocz do pozycji: 1.

Tytuł:

Zosuquidar: An Effective Molecule for Intracellular Ca Measurement in P-gp Positive Cells.

Autorzy:

Pelegrinova L; Institute of Molecular Physiology and Genetics, Centre of Bioscience, Slovak Academy of Sciences, Dúbravská Cesta 9, 845 05 Bratislava, Slovakia.; Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.
Sofrankova L; Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.
Spaldova J; Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.
Stefik P; Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.
Sulova Z; Institute of Molecular Physiology and Genetics, Centre of Bioscience, Slovak Academy of Sciences, Dúbravská Cesta 9, 845 05 Bratislava, Slovakia.
Breier A; Institute of Molecular Physiology and Genetics, Centre of Bioscience, Slovak Academy of Sciences, Dúbravská Cesta 9, 845 05 Bratislava, Slovakia.; Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.
Elefantova K; Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 812 37 Bratislava, Slovakia.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2024 Mar 07; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 07.

Typ publikacji:

Journal Article

MeSH Terms:

Calcium*/metabolism
Drug Resistance, Multiple*
ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics ; ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism ; ATP-Binding Cassette Transporters/metabolism ; Drug Resistance, Neoplasm ; Cell Line, Tumor

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 2.

Tytuł:

The Combination of Antibiotic and Non-Antibiotic Compounds Improves Antibiotic Efficacy against Multidrug-Resistant Bacteria.

Autorzy:

Xiao G; College of Veterinary Medicine, Hunan Agricultural University, Changsha 410128, China.
Li J; College of Veterinary Medicine, Hunan Agricultural University, Changsha 410128, China.
Sun Z; College of Veterinary Medicine, Hunan Agricultural University, Changsha 410128, China.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 Oct 23; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 23.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Anti-Bacterial Agents*/pharmacology
Anti-Bacterial Agents*/therapeutic use
Drug Resistance, Multiple, Bacterial*
Bacteria ; Drug Resistance, Bacterial ; Microbial Sensitivity Tests

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 3.

Tytuł:

SuperNatural inhibitors to reverse multidrug resistance emerged by ABCB1 transporter: Database mining, lipid-mediated molecular dynamics, and pharmacokinetics study.

Autorzy:

Ibrahim MAA; Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, Egypt.; School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Abdeljawaad KAA; Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, Egypt.
Abdelrahman AHM; Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, Egypt.
Abdelhamid MMH; Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, Egypt.
Naeem MA; Nutrition and Food Sciences, Ain Shams University Specialized Hospital, Ain Shams University, Cairo, Egypt.
Mekhemer GAH; Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, Egypt.
Sidhom PA; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
Sayed SRM; Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Paré PW; Department of Chemistry & Biochemistry, Texas Tech University, Lubbock, Texas, United States of America.
Hegazy MF; Chemistry of Medicinal Plants Department, National Research Centre, Giza, Egypt.

Pokaż więcej

Źródło:

PloS one [PLoS One] 2023 Jul 26; Vol. 18 (7), pp. e0288919. Date of Electronic Publication: 2023 Jul 26 (Print Publication: 2023).

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Molecular Dynamics Simulation*
Drug Resistance, Neoplasm*
ATP Binding Cassette Transporter, Subfamily B/metabolism ; Drug Resistance, Multiple ; Lipids/pharmacology ; Molecular Docking Simulation ; Cell Line, Tumor

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 4.

Tytuł:

Design, Synthesis, and Antiproliferative Activity of Benzopyran-4-One-Isoxazole Hybrid Compounds.

Autorzy:

Gupta S; Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinker Health Science Campus, Irvine, CA 92618-1908, USA.; Department of Chemistry, Hindu College, Sonipat 131001, India.
Park SE; Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinker Health Science Campus, Irvine, CA 92618-1908, USA.
Mozaffari S; Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinker Health Science Campus, Irvine, CA 92618-1908, USA.
El-Aarag B; Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinker Health Science Campus, Irvine, CA 92618-1908, USA.; Biochemistry Division, Chemistry Department, Faculty of Science, Menoufia University, Shebin El-Koom 32512, Egypt.
Parang K; Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinker Health Science Campus, Irvine, CA 92618-1908, USA.
Tiwari RK; Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinker Health Science Campus, Irvine, CA 92618-1908, USA.

Pokaż więcej

Źródło:

Molecules (Basel, Switzerland) [Molecules] 2023 May 21; Vol. 28 (10). Date of Electronic Publication: 2023 May 21.

Typ publikacji:

Journal Article

MeSH Terms:

Drug Resistance, Multiple*
Antineoplastic Agents*/pharmacology
Humans ; HEK293 Cells ; Cell Line, Tumor ; Drug Resistance, Neoplasm ; Drug Screening Assays, Antitumor ; Benzopyrans/pharmacology ; Cell Proliferation ; Structure-Activity Relationship ; Molecular Structure ; Dose-Response Relationship, Drug

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 5.

Tytuł:

Alpha-1 antitrypsin expression is upregulated in multidrug-resistant cancer cells.

Autorzy:

Divac Rankov A; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Jovanović Stojanov S; Department of Neurobiology, Institute for Biological Research 'Sinisa Stankovic' - National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia.
Dragoj M; Department of Neurobiology, Institute for Biological Research 'Sinisa Stankovic' - National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia.
Ljujić M; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia. .

Pokaż więcej

Źródło:

Histochemistry and cell biology [Histochem Cell Biol] 2023 May; Vol. 159 (5), pp. 431-437. Date of Electronic Publication: 2022 Dec 19.

Typ publikacji:

Journal Article

MeSH Terms:

Drug Resistance, Multiple*
Glioblastoma*/drug therapy
Glioblastoma*/genetics
Humans ; Interleukin-6 ; Drug Resistance, Neoplasm

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 6.

Tytuł:

Identification and Empiric Evaluation of New Inhibitors of the Multidrug Transporter P-Glycoprotein (ABCB1).

Autorzy:

Cheema Y; School of Interdisciplinary Engineering & Sciences (SINES), National University of Science and Technology, Sector H-12, Islamabad 44000, Pakistan.; Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.
Kiani YS; School of Interdisciplinary Engineering & Sciences (SINES), National University of Science and Technology, Sector H-12, Islamabad 44000, Pakistan.
Linton KJ; Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.
Jabeen I; School of Interdisciplinary Engineering & Sciences (SINES), National University of Science and Technology, Sector H-12, Islamabad 44000, Pakistan.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 Mar 10; Vol. 24 (6). Date of Electronic Publication: 2023 Mar 10.

Typ publikacji:

Journal Article

MeSH Terms:

Drug Resistance, Multiple*
Antineoplastic Agents*/pharmacology
Cryoelectron Microscopy ; ATP Binding Cassette Transporter, Subfamily B/metabolism ; Drug Resistance ; Paclitaxel/pharmacology ; Drug Resistance, Neoplasm ; Cell Line, Tumor

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 7.

Tytuł:

Serotype distribution, trend of multidrug resistance and prevalence of β-lactamase resistance genes in human Salmonella isolates from clinical specimens in Guizhou, China.

Autorzy:

Wei X; Laboratory of Bacterial Infectious Disease, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, People's Republic of China.
Long L; Laboratory of Infectious Disease, Tongren City Center for Disease Control and Prevention, Guiyang, People's Republic of China.
You L; Laboratory of Bacterial Infectious Disease, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, People's Republic of China.
Wang M; Laboratory of Bacterial Infectious Disease, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, People's Republic of China.
Wang D; Institute of Communicable Disease Control and Prevention, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, People's Republic of China.
Liu C; Laboratory of Bacterial Infectious Disease, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, People's Republic of China.
Li S; Laboratory of Bacterial Infectious Disease, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, People's Republic of China.
Wang J; School of Public Health, the Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, People's Republic of China.

Pokaż więcej

Źródło:

PloS one [PLoS One] 2023 Apr 20; Vol. 18 (4), pp. e0282254. Date of Electronic Publication: 2023 Apr 20 (Print Publication: 2023).

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Anti-Bacterial Agents*/pharmacology
Anti-Bacterial Agents*/therapeutic use
Drug Resistance, Multiple, Bacterial*/genetics
Humans ; Serogroup ; Prevalence ; Salmonella ; beta-Lactam Resistance ; China/epidemiology ; Microbial Sensitivity Tests ; Drug Resistance, Bacterial

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 8.

Tytuł:

ABCB1 and ABCG2 Overexpression Mediates Resistance to the Phosphatidylinositol 3-Kinase Inhibitor HS-173 in Cancer Cell Lines.

Autorzy:

Wu CP; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Department of Physiology and Pharmacology, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Molecular Medicine Research Center, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Department of Obstetrics and Gynecology, Taipei Chang Gung Memorial Hospital, Taipei 10507, Taiwan.
Hung CY; Molecular Medicine Research Center, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
Hsieh YJ; Molecular Medicine Research Center, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
Murakami M; Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Huang YH; Department of Obstetrics and Gynecology, Taipei Chang Gung Memorial Hospital, Taipei 10507, Taiwan.
Su TY; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
Hung TH; Department of Obstetrics and Gynecology, Taipei Chang Gung Memorial Hospital, Taipei 10507, Taiwan.; Department of Medicine, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Department of Obstetrics and Gynecology, Keelung Chang Gung Memorial Hospital, Keelung 20401, Taiwan.
Yu JS; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Molecular Medicine Research Center, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.; Liver Research Center, Linkou Chang Gung Memorial Hospital, Taoyuan 33302, Taiwan.
Wu YS; Department of Chemistry, Tunghai University, Taichung 40704, Taiwan.
Ambudkar SV; Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

Pokaż więcej

Źródło:

Cells [Cells] 2023 Mar 30; Vol. 12 (7). Date of Electronic Publication: 2023 Mar 30.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural

MeSH Terms:

Drug Resistance, Multiple*
Neoplasms*/drug therapy
Humans ; Phosphatidylinositol 3-Kinases/metabolism ; Apoptosis ; Drug Resistance, Neoplasm ; Cell Line, Tumor ; G2 Phase Cell Cycle Checkpoints ; ATP-Binding Cassette Transporters/metabolism ; Phosphoinositide-3 Kinase Inhibitors/pharmacology ; ATP Binding Cassette Transporter, Subfamily G, Member 2/metabolism ; Neoplasm Proteins/metabolism ; ATP Binding Cassette Transporter, Subfamily B

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 9.

Tytuł:

Degradation trumps mutations in cancer.

Autorzy:

Davis RE; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
Westin JR; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.

Pokaż więcej

Źródło:

Science (New York, N.Y.) [Science] 2024 Feb 02; Vol. 383 (6682), pp. 480-481. Date of Electronic Publication: 2024 Feb 01.

Typ publikacji:

Journal Article

MeSH Terms:

Drug Resistance, Neoplasm*/drug effects
Drug Resistance, Neoplasm*/genetics
Protein Kinase Inhibitors*/pharmacology
Protein Kinase Inhibitors*/therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell*/genetics
Proteolysis*/drug effects
Cell Line, Tumor ; Mutation ; Humans

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 10.

Tytuł:

The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells.

Autorzy:

Bakadlag R; Institute of Parasitology, Macdonald Campus, McGill University, Ste. Anne de Bellevue, Québec, H9X-3V9, Canada.
Limniatis G; Institute of Parasitology, Macdonald Campus, McGill University, Ste. Anne de Bellevue, Québec, H9X-3V9, Canada.
Georges G; Department of Cardiac Surgery, Quebec Heart & Lung Institute, Université Laval, Québec, Canada.
Georges E; Institute of Parasitology, Macdonald Campus, McGill University, Ste. Anne de Bellevue, Québec, H9X-3V9, Canada. .

Pokaż więcej

Źródło:

BMC cancer [BMC Cancer] 2023 Jan 06; Vol. 23 (1), pp. 24. Date of Electronic Publication: 2023 Jan 06.

Typ publikacji:

Journal Article

MeSH Terms:

ATP Binding Cassette Transporter, Subfamily B, Member 1*/genetics
ATP Binding Cassette Transporter, Subfamily B, Member 1*/metabolism
Drug Resistance, Multiple*
Humans ; Reactive Oxygen Species/metabolism ; Receptors, Estrogen/metabolism ; ATP Binding Cassette Transporter, Subfamily B/genetics ; Tamoxifen/pharmacology ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Adenosine Triphosphatases/metabolism ; Drug Resistance, Neoplasm ; Cell Line, Tumor

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 11.

Tytuł:

Global epistasis in plasmid-mediated antimicrobial resistance.

Autorzy:

DelaFuente J; Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain.
Diaz-Colunga J; Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain.; Institute of Functional Biology & Genomics, IBFG - CSIC, Universidad de Salamanca, Salamanca, Spain.
Sanchez A; Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain. .; Institute of Functional Biology & Genomics, IBFG - CSIC, Universidad de Salamanca, Salamanca, Spain. .
San Millan A; Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain. .; Centro de Investigación Biológica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain. .

Pokaż więcej

Źródło:

Molecular systems biology [Mol Syst Biol] 2024 Apr; Vol. 20 (4), pp. 311-320. Date of Electronic Publication: 2024 Feb 26.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Anti-Bacterial Agents*/pharmacology
Drug Resistance, Bacterial*/genetics
Epistasis, Genetic ; Plasmids/genetics ; Genome, Bacterial ; Bacteria/genetics

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 12.

Tytuł:

China's plan to combat antimicrobial resistance.

Autorzy:

Li X; Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province, Hangzhou, China.
Wu Y; Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province, Hangzhou, China.
Jiang T; Department of Clinical Laboratory, Affiliated Wenling Hospital, Wenzhou Medical University, Wenling, China.
Chen B; Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province, Hangzhou, China.
Feng R; College of Environmental and Resource Sciences, Zhejiang University, Hangzhou, China.
Zhang J; Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province, Hangzhou, China.
Xie X; Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province, Hangzhou, China.
Ruan Z; Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province, Hangzhou, China.

Pokaż więcej

Źródło:

Science (New York, N.Y.) [Science] 2024 Mar 29; Vol. 383 (6690), pp. 1424-1425. Date of Electronic Publication: 2024 Mar 28.

Typ publikacji:

Letter

MeSH Terms:

Anti-Bacterial Agents*/adverse effects
Drug Resistance, Multiple, Bacterial*
Antimicrobial Stewardship*/methods
China ; Humans ; Animals

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 13.

Tytuł:

Discovery of Novel 4-Hydroxyquinazoline Derivatives: In Silico, In Vivo and In Vitro Studies Using Primary PARPi-Resistant Cell Lines.

Autorzy:

Zhu L; School of Pharmacy, Shandong Second Medical University, Weifang 261053, China.
Liu B; School of Pharmacy, Shandong Second Medical University, Weifang 261053, China.
Jin F; School of Pharmacy, Shandong Second Medical University, Weifang 261053, China.
Cao W; School of Pharmacy, Shandong Second Medical University, Weifang 261053, China.
Xu G; School of Pharmacy, Shandong Second Medical University, Weifang 261053, China.
Zhang X; School of Pharmacy, Shandong Second Medical University, Weifang 261053, China.
Peng P; School of Pharmacy (Preparatory), East China Normal University, Shanghai 200241, China.
Gao D; The Research Center of Chiral Drugs, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Wang B; School of Pharmacy, Shandong Second Medical University, Weifang 261053, China.
Feng K; School of Pharmacy, Shandong Second Medical University, Weifang 261053, China.

Pokaż więcej

Źródło:

Molecules (Basel, Switzerland) [Molecules] 2024 Mar 21; Vol. 29 (6). Date of Electronic Publication: 2024 Mar 21.

Typ publikacji:

Journal Article

MeSH Terms:

Drug Resistance, Neoplasm*
Antineoplastic Agents*/pharmacology
Quinazolinones*
Molecular Docking Simulation ; Cell Line, Tumor

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 14.

Tytuł:

Role of CD44 in Chemotherapy Treatment Outcome: A Scoping Review of Clinical Studies.

Autorzy:

Wu Z; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Lu J; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Loo A; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Ho N; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Nguyen D; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Cheng PY; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Mohammed AI; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Cirillo N; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.; School of Dentistry, University of Jordan, Amman 11942, Jordan.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2024 Mar 08; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 08.

Typ publikacji:

Systematic Review; Journal Article; Review

MeSH Terms:

Drug Resistance, Neoplasm*
Hyaluronan Receptors*/genetics
Hyaluronan Receptors*/metabolism
Humans ; Treatment Outcome

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 15.

Tytuł:

Defects of mitochondria-lysosomes communication induce secretion of mitochondria-derived vesicles and drive chemoresistance in ovarian cancer cells.

Autorzy:

Gagliardi S; Department of Biological and Environmental Sciences and Technologies, University of Salento, Via Provinciale Lecce-Monteroni n. 165, Lecce, 73100, Italy.
Mitruccio M; Department of Biological and Environmental Sciences and Technologies, University of Salento, Via Provinciale Lecce-Monteroni n. 165, Lecce, 73100, Italy.
Di Corato R; Institute for Microelectronics and Microsystems (IMM), CNR, Via Monteroni, Lecce, 73100, Italy.; Center for Biomolecular Nanotechnologies, Istituto Italiano di Tecnologia, Arnesano, 73010, Italy.
Romano R; Department of Biological and Environmental Sciences and Technologies, University of Salento, Via Provinciale Lecce-Monteroni n. 165, Lecce, 73100, Italy.; Department of Experimental Medicine, University of Salento, Via Provinciale Lecce-Monteroni n. 165, Lecce, 73100, Italy.
Aloisi A; Institute for Microelectronics and Microsystems (IMM), CNR, Via Monteroni, Lecce, 73100, Italy.
Rinaldi R; Department of Mathematics and Physics 'E. De Giorgi', University of Salento, Via Monteroni, Lecce, 73100, Italy.; Scuola Superiore ISUFI, University of Salento, Via Monteroni, University Campus, Lecce, 73100, Italy.
Alifano P; Department of Biological and Environmental Sciences and Technologies, University of Salento, Via Provinciale Lecce-Monteroni n. 165, Lecce, 73100, Italy.; Department of Experimental Medicine, University of Salento, Via Provinciale Lecce-Monteroni n. 165, Lecce, 73100, Italy.
Guerra F; Department of Biological and Environmental Sciences and Technologies, University of Salento, Via Provinciale Lecce-Monteroni n. 165, Lecce, 73100, Italy.
Bucci C; Department of Biological and Environmental Sciences and Technologies, University of Salento, Via Provinciale Lecce-Monteroni n. 165, Lecce, 73100, Italy. .; Department of Experimental Medicine, University of Salento, Via Provinciale Lecce-Monteroni n. 165, Lecce, 73100, Italy. .

Pokaż więcej

Źródło:

Cell communication and signaling : CCS [Cell Commun Signal] 2024 Mar 06; Vol. 22 (1), pp. 165. Date of Electronic Publication: 2024 Mar 06.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Drug Resistance, Neoplasm*
Ovarian Neoplasms*/drug therapy
Female ; Humans ; Lysosomes ; Mitochondria ; Cisplatin/pharmacology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 16.

Tytuł:

Antimicrobial resistance patterns, virulence genes, and biofilm formation in enterococci strains collected from different sources.

Autorzy:

Ghazvinian M; Molecular and Cell Biology Research Centre, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Department of Medical Microbiology and Virology, Faculty of Medicine, Mazandaran University of Medical Sciences, Farah Abad Blv, Khazar Square, Sari, Mazandaran, Iran.
Asgharzadeh Marghmalek S; Molecular and Cell Biology Research Centre, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Department of Medical Microbiology and Virology, Faculty of Medicine, Mazandaran University of Medical Sciences, Farah Abad Blv, Khazar Square, Sari, Mazandaran, Iran.
Gholami M; Department of Medical Microbiology and Virology, Faculty of Medicine, Mazandaran University of Medical Sciences, Farah Abad Blv, Khazar Square, Sari, Mazandaran, Iran.
Amir Gholami S; Molecular and Cell Biology Research Centre, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Department of Medical Microbiology and Virology, Faculty of Medicine, Mazandaran University of Medical Sciences, Farah Abad Blv, Khazar Square, Sari, Mazandaran, Iran.
Amiri E; Department of Medical Microbiology and Virology, Faculty of Medicine, Mazandaran University of Medical Sciences, Farah Abad Blv, Khazar Square, Sari, Mazandaran, Iran.
Goli HR; Molecular and Cell Biology Research Centre, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. .; Department of Medical Microbiology and Virology, Faculty of Medicine, Mazandaran University of Medical Sciences, Farah Abad Blv, Khazar Square, Sari, Mazandaran, Iran. .

Pokaż więcej

Źródło:

BMC infectious diseases [BMC Infect Dis] 2024 Mar 04; Vol. 24 (1), pp. 274. Date of Electronic Publication: 2024 Mar 04.

Typ publikacji:

Journal Article

MeSH Terms:

Anti-Bacterial Agents*/pharmacology
Drug Resistance, Bacterial*/genetics
Humans ; Cross-Sectional Studies ; Virulence/genetics ; Kanamycin ; Biofilms

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 17.

Tytuł:

Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway.

Autorzy:

Cheng B; Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.; Department of Urology, Fujian Medical University Union Hospital, Fuzhou, China.
Li L; Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.
Luo T; Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.
Wang Q; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 511430, China.
Luo Y; Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.
Bai S; Department of Radiation Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.
Li K; Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China. .
Lai Y; Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China. .
Huang H; Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China. .; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China. .; Guangdong Provincial Clinical Research Center for Urological Diseases, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China. .; Department of Urology, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, 511518, Guangdong, China. .

Pokaż więcej

Źródło:

Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 01; Vol. 43 (1), pp. 67. Date of Electronic Publication: 2024 Mar 01.

Typ publikacji:

Journal Article

MeSH Terms:

Interleukin-11*/genetics
Interleukin-11*/metabolism
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/genetics
Prostatic Neoplasms*/metabolism
Drug Resistance, Neoplasm*/genetics
Humans ; Male ; Docetaxel/pharmacology ; Gene Expression Regulation ; Janus Kinase 1/genetics ; Janus Kinase 1/metabolism ; Signal Transduction ; STAT4 Transcription Factor/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 18.

Tytuł:

Prevalence and changing antimicrobial resistance profiles of Shigella spp. isolated from diarrheal patients in Kolkata during 2011-2019.

Autorzy:

Bose P; Division of Bacteriology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India.
Chowdhury G; Division of Bacteriology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India.; Collaborative Research Centre of Okayama University for Infectious Diseases at ICMR-NICED, Kolkata, India.
Halder G; Division of Bacteriology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India.
Ghosh D; Division of Bacteriology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India.
Deb AK; Division of Epidemiology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India.
Kitahara K; Collaborative Research Centre of Okayama University for Infectious Diseases at ICMR-NICED, Kolkata, India.; Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Miyoshi SI; Collaborative Research Centre of Okayama University for Infectious Diseases at ICMR-NICED, Kolkata, India.; Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Morita M; Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan.
Ramamurthy T; Division of Bacteriology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India.
Dutta S; Division of Bacteriology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India.
Mukhopadhyay AK; Division of Bacteriology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India.

Pokaż więcej

Źródło:

PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 Feb 20; Vol. 18 (2), pp. e0011964. Date of Electronic Publication: 2024 Feb 20 (Print Publication: 2024).

Typ publikacji:

Journal Article

MeSH Terms:

Anti-Bacterial Agents*/pharmacology
Drug Resistance, Bacterial*
Humans ; Prevalence ; Chloramphenicol ; Diarrhea/epidemiology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 19.

Tytuł:

Inhibition of LATS kinases reduces tumorigenicity and increases the sensitivity of human chronic myelogenous leukemia cells to imatinib.

Autorzy:

Klaihmon P; Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Lorthongpanich C; Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. .; Blood Products and Cellular Immunotherapy Research Group, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand. .
Kheolamai P; Center of Excellence in Stem Cell Research and Innovations, Division of Cell Biology, Faculty of Medicine, Thammasat University, Pathumthani, Thailand. .
Saisaard W; Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Issaragrisil S; Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.; Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Pokaż więcej

Źródło:

Scientific reports [Sci Rep] 2024 Feb 18; Vol. 14 (1), pp. 3993. Date of Electronic Publication: 2024 Feb 18.

Typ publikacji:

Journal Article

MeSH Terms:

Drug Resistance, Neoplasm*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/pathology
Humans ; Imatinib Mesylate/pharmacology ; Imatinib Mesylate/therapeutic use ; Fusion Proteins, bcr-abl/genetics ; Protein Serine-Threonine Kinases ; K562 Cells ; Apoptosis ; Tumor Suppressor Proteins

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 20.

Tytuł:

HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process.

Autorzy:

Ma S; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China.; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China.; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China.
Wang J; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China.
Cui Z; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China.
Yang X; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China.; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China.; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China.
Cui X; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China.; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China.; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China.
Li X; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China.; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China.; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China.
Zhao L; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China. .; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China. .; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, People's Republic of China. .; Precision Medicine Center, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. .

Pokaż więcej

Źródło:

Scientific reports [Sci Rep] 2024 Feb 16; Vol. 14 (1), pp. 3870. Date of Electronic Publication: 2024 Feb 16.

Typ publikacji:

Journal Article

MeSH Terms:

Apoptosis*/genetics
Drug Resistance, Neoplasm*/genetics
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Female ; Humans ; Basic Helix-Loop-Helix Transcription Factors/metabolism ; Cell Line, Tumor ; Cell Proliferation ; Cisplatin/pharmacology ; DNA Repair ; Hypoxia ; Phosphatidylinositol 3-Kinases/genetics ; Phosphatidylinositol 3-Kinases/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Tumor Microenvironment

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 21.

Tytuł:

An antibiotic preorganized for ribosomal binding overcomes antimicrobial resistance.

Autorzy:

Wu KJY; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Tresco BIC; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Ramkissoon A; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Aleksandrova EV; Department of Biological Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA.
Syroegin EA; Department of Biological Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA.
See DNY; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Liow P; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Dittemore GA; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Yu M; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Testolin G; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Mitcheltree MJ; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Liu RY; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Svetlov MS; Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA.; Center for Biomolecular Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA.
Polikanov YS; Department of Biological Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA.; Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA.; Center for Biomolecular Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA.
Myers AG; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.

Pokaż więcej

Źródło:

Science (New York, N.Y.) [Science] 2024 Feb 16; Vol. 383 (6684), pp. 721-726. Date of Electronic Publication: 2024 Feb 15.

Typ publikacji:

Journal Article

MeSH Terms:

Anti-Bacterial Agents*/chemical synthesis
Anti-Bacterial Agents*/chemistry
Anti-Bacterial Agents*/pharmacology
Drug Resistance, Multiple, Bacterial*
Bridged-Ring Compounds*/chemical synthesis
Bridged-Ring Compounds*/chemistry
Bridged-Ring Compounds*/pharmacology
Oxepins*/chemical synthesis
Oxepins*/chemistry
Oxepins*/pharmacology
Lincosamides*/chemical synthesis
Lincosamides*/chemistry
Lincosamides*/pharmacology
Erythromycin/chemistry ; Erythromycin/pharmacology ; Microbial Sensitivity Tests ; Staphylococcus aureus/drug effects ; Escherichia coli/drug effects ; Pseudomonas aeruginosa/drug effects ; Animals ; Mice ; Drug Design ; Ribosomes/chemistry

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 22.

Tytuł:

Understanding the lived-experience and support-needs of people living with antimicrobial resistance in the UK through interpretative phenomenological analysis.

Autorzy:

Hamilton RA; School of Pharmacy, De Montfort University, Leicester, UK. .
Lond B; Department of Psychology, De Montfort University, Leicester, UK.
Wilde L; School of Pharmacy, De Montfort University, Leicester, UK.
Williamson I; Department of Psychology, De Montfort University, Leicester, UK.

Pokaż więcej

Źródło:

Scientific reports [Sci Rep] 2024 Feb 10; Vol. 14 (1), pp. 3403. Date of Electronic Publication: 2024 Feb 10.

Typ publikacji:

Journal Article

MeSH Terms:

Anti-Bacterial Agents*
Drug Resistance, Bacterial*
Humans ; Qualitative Research ; Friends ; United Kingdom

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 23.

Tytuł:

Assessment of global antimicrobial resistance campaigns conducted to improve public awareness and antimicrobial use behaviours: a rapid systematic review.

Autorzy:

Gilham EL; HCAI and AMR Division, Health Security Agency, London, UK.
Pearce-Smith N; HCAI and AMR Division, Health Security Agency, London, UK.
Carter V; The AMR Narrative, Altrincham, UK.
Ashiru-Oredope D; HCAI and AMR Division, Health Security Agency, London, UK. .; School of Pharmacy, University of Nottingham, Nottingham, UK. .

Pokaż więcej

Źródło:

BMC public health [BMC Public Health] 2024 Feb 06; Vol. 24 (1), pp. 396. Date of Electronic Publication: 2024 Feb 06.

Typ publikacji:

Systematic Review; Journal Article

MeSH Terms:

Anti-Bacterial Agents*/therapeutic use
Drug Resistance, Bacterial*
Humans ; Health Promotion/methods

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 24.

Tytuł:

Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127.

Autorzy:

Montoya S; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Bourcier J; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Noviski M; Nurix Therapeutics, San Francisco, CA, USA.
Lu H; Nurix Therapeutics, San Francisco, CA, USA.
Thompson MC; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Chirino A; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Jahn J; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Sondhi AK; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Gajewski S; Nurix Therapeutics, San Francisco, CA, USA.
Tan YSM; Nurix Therapeutics, San Francisco, CA, USA.
Yung S; Nurix Therapeutics, San Francisco, CA, USA.
Urban A; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Wang E; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Han C; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Mi X; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Kim WJ; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Sievers Q; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Auger P; Nurix Therapeutics, San Francisco, CA, USA.
Bousquet H; Nurix Therapeutics, San Francisco, CA, USA.
Brathaban N; Nurix Therapeutics, San Francisco, CA, USA.
Bravo B; Nurix Therapeutics, San Francisco, CA, USA.
Gessner M; Nurix Therapeutics, San Francisco, CA, USA.
Guiducci C; Nurix Therapeutics, San Francisco, CA, USA.
Iuliano JN; Nurix Therapeutics, San Francisco, CA, USA.
Kane T; Nurix Therapeutics, San Francisco, CA, USA.
Mukerji R; Nurix Therapeutics, San Francisco, CA, USA.
Reddy PJ; Nurix Therapeutics, San Francisco, CA, USA.
Powers J; Nurix Therapeutics, San Francisco, CA, USA.
Sanchez Garcia de Los Rios M; Nurix Therapeutics, San Francisco, CA, USA.
Ye J; Nurix Therapeutics, San Francisco, CA, USA.
Barrientos Risso C; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Tsai D; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Pardo G; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Notti RQ; Laboratory of Molecular Electron Microscopy, Rockefeller University, New York, NY, USA.
Pardo A; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Affer M; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Nawaratne V; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Totiger TM; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Pena-Velasquez C; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Rhodes JM; Division of Hematology-Oncology, Department of Medicine at Zucker School of Medicine at Hofstra/Northwell, CLL Research and Treatment Center, Lake Success, NY, USA.
Zelenetz AD; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Alencar A; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
Roeker LE; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Mehta S; Gene Editing and Screening Core Facility, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Institute and Cancer Center, New York, NY, USA.
Garippa R; Gene Editing and Screening Core Facility, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Institute and Cancer Center, New York, NY, USA.
Linley A; Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
Soni RK; Proteomics and Macromolecular Crystallography Shared Resource, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA.
Skånland SS; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Brown RJ; Nurix Therapeutics, San Francisco, CA, USA.
Mato AR; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Hansen GM; Nurix Therapeutics, San Francisco, CA, USA.
Abdel-Wahab O; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Taylor J; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.

Pokaż więcej

Źródło:

Science (New York, N.Y.) [Science] 2024 Feb 02; Vol. 383 (6682), pp. eadi5798. Date of Electronic Publication: 2024 Feb 02.

Typ publikacji:

Journal Article

MeSH Terms:

Agammaglobulinaemia Tyrosine Kinase*/genetics
Agammaglobulinaemia Tyrosine Kinase*/metabolism
Ikaros Transcription Factor*/metabolism
Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell*/genetics
Protein Kinase Inhibitors*/pharmacology
Protein Kinase Inhibitors*/therapeutic use
Proteolysis*/drug effects
Drug Resistance, Neoplasm*/drug effects
Humans ; Mutation ; Phosphorylation ; Signal Transduction

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 25.

Tytuł:

Characterization of a Potent, Selective, and Safe Inhibitor, Ac15(Az8) 2 , in Reversing Multidrug Resistance Mediated by Breast Cancer Resistance Protein (BCRP/ABCG2).

Autorzy:

Chong TC; Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong, China.
Wong ILK; Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong, China.
Cui J; Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong, China.; School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.
Law MC; Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong, China.
Zhu X; Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong, China.
Hu X; Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong, China.
Kan JWY; Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong, China.
Yan CSW; Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong, China.
Chan TH; Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong, China.; Department of Chemistry, McGill University, Montreal, QC H3A 2K6, Canada.
Chow LMC; Department of Applied Biology and Chemical Technology and State Key Laboratory of Chemical Biology and Drug Discovery, Hong Kong Polytechnic University, Hong Kong, China.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2022 Oct 31; Vol. 23 (21). Date of Electronic Publication: 2022 Oct 31.

Typ publikacji:

Journal Article

MeSH Terms:

Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/chemistry
ATP Binding Cassette Transporter, Subfamily G, Member 2*/antagonists & inhibitors
ATP Binding Cassette Transporter, Subfamily G, Member 2*/metabolism
Drug Resistance, Neoplasm*/drug effects
Drug Resistance, Neoplasm*/genetics
Animals ; Humans ; Mice ; ATP-Binding Cassette Transporters/metabolism ; Cell Line, Tumor ; Drug Resistance, Multiple ; Mice, Nude ; Neoplasm Proteins/metabolism ; Neoplasms/drug therapy ; Topotecan/pharmacology ; Flavonoids/pharmacology ; Triazoles/pharmacology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 26.

Tytuł:

Patterns of antimicrobial resistance in Salmonella isolates from fattening pigs in Spain.

Autorzy:

Teng KT; VISAVET Health Surveillance Centre, Universidad Complutense, Madrid, Spain. .; Department of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing University, Taichung City, Taiwan. .
Aerts M; Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Hasselt University, Diepenbeek, Belgium.; Data Science Institute, Hasselt University, Diepenbeek, Belgium.
Jaspers S; Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Hasselt University, Diepenbeek, Belgium.; Data Science Institute, Hasselt University, Diepenbeek, Belgium.
Ugarte-Ruiz M; VISAVET Health Surveillance Centre, Universidad Complutense, Madrid, Spain.
Moreno MA; VISAVET Health Surveillance Centre, Universidad Complutense, Madrid, Spain.; Department of Animal Health, Faculty of Veterinary Medicine, Universidad Complutense, Madrid, Spain.
Saez JL; Subdirección General de Sanidad e Higiene Animal y Trazabilidad, Dirección General de La Producción Agraria, Ministerio de Agricultura, Pesca y Alimentación, Madrid, Spain.
Collado S; Subdirección General de Sanidad e Higiene Animal y Trazabilidad, Dirección General de La Producción Agraria, Ministerio de Agricultura, Pesca y Alimentación, Madrid, Spain.
de Frutos C; Laboratorio Central de Veterinaria (LCV Algete), Ministerio de Agricultura, Pesca y Alimentación, Madrid, Spain.
Dominguez L; VISAVET Health Surveillance Centre, Universidad Complutense, Madrid, Spain.; Department of Animal Health, Faculty of Veterinary Medicine, Universidad Complutense, Madrid, Spain.
Alvarez J; VISAVET Health Surveillance Centre, Universidad Complutense, Madrid, Spain.; Department of Animal Health, Faculty of Veterinary Medicine, Universidad Complutense, Madrid, Spain.

Pokaż więcej

Źródło:

BMC veterinary research [BMC Vet Res] 2022 Sep 03; Vol. 18 (1), pp. 333. Date of Electronic Publication: 2022 Sep 03.

Typ publikacji:

Journal Article

MeSH Terms:

Anti-Bacterial Agents*/pharmacology
Drug Resistance, Multiple, Bacterial*
Animals ; Bayes Theorem ; Chloramphenicol ; Ciprofloxacin ; Drug Resistance, Bacterial ; Microbial Sensitivity Tests/veterinary ; Nalidixic Acid ; Salmonella ; Spain/epidemiology ; Sulfamethoxazole ; Swine

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 27.

Tytuł:

Surveillance of bacterial load and multi-drug resistant bacteria on bedsheets in a primary health care unit.

Autorzy:

Varshney S; Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi, New Delhi, India.
Sharma S; Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi, New Delhi, India.
Gupta D; Department of Textile and Fibre Engineering, Indian Institute of Technology Delhi, New Delhi, India.

Pokaż więcej

Źródło:

International journal of environmental health research [Int J Environ Health Res] 2022 Sep; Vol. 32 (9), pp. 2040-2051. Date of Electronic Publication: 2021 Jun 18.

Typ publikacji:

Journal Article

MeSH Terms:

Anti-Bacterial Agents*/pharmacology
Drug Resistance, Multiple, Bacterial*
Bacteria ; Bacterial Load ; Drug Resistance, Bacterial ; Humans ; Microbial Sensitivity Tests ; Primary Health Care

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 28.

Tytuł:

IFITM3-mediated activation of TRAF6/MAPK/AP-1 pathways induces acquired TKI resistance in clear cell renal cell carcinoma.

Autorzy:

Jeong SU; Department of Pathology, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea.
Park JM; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Yoon SY; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Hwang HS; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Go H; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Shin DM; Department of Cell and Genetic Engineering, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Ju H; Department of Cell and Genetic Engineering, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Sung CO; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Lee JL; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Jeong G; AI Recommendation, T3K, SK Telecom, Seoul, Korea.
Cho YM; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. .

Pokaż więcej

Źródło:

Investigative and clinical urology [Investig Clin Urol] 2024 Jan; Vol. 65 (1), pp. 84-93.

Typ publikacji:

Journal Article

MeSH Terms:

Carcinoma, Renal Cell*/drug therapy
Membrane Proteins*/genetics
RNA-Binding Proteins*/genetics
Tyrosine Kinase Inhibitors*/pharmacology
Drug Resistance, Neoplasm*
Humans ; Sunitinib/pharmacology ; TNF Receptor-Associated Factor 6 ; Transcription Factor AP-1 ; Vascular Endothelial Growth Factor A

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 29.

Tytuł:

Down-regulation of ABCB1 by collateral sensitivity drugs reverses multidrug resistance and up-regulates enolase I.

Autorzy:

Limniatis G; Institute of Parasitology, McGill University, Quebec, Canada.
Georges E; Institute of Parasitology, McGill University, Quebec, Canada.

Pokaż więcej

Źródło:

Journal of biochemistry [J Biochem] 2022 Jun 28; Vol. 172 (1), pp. 37-48.

Typ publikacji:

Journal Article

MeSH Terms:

ATP Binding Cassette Transporter, Subfamily B*/genetics
Antineoplastic Agents*/pharmacology
Breast Neoplasms*/drug therapy
Drug Resistance, Neoplasm*
Cell Line, Tumor ; Down-Regulation ; Drug Collateral Sensitivity ; Drug Resistance, Multiple ; Female ; Humans ; Phosphopyruvate Hydratase/pharmacology ; Tamoxifen/pharmacology ; Verapamil/pharmacology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 30.

Tytuł:

The Relationship between Trop-2, Chemotherapeutic Drugs, and Chemoresistance.

Autorzy:

Koltai T; Hospital del Centro Gallego de Buenos Aires, Buenos Aires 2199, Argentina.
Fliegel L; Department of Biochemistry, Faculty of Medicine, University of Alberta, 347 Medical Science Bldg., Edmonton, AB T6G 2H7, Canada.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 Dec 20; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 20.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Drug Resistance, Neoplasm*
Amyloidosis, Familial*
Female ; Pregnancy ; Animals ; Biological Transport ; Calcium, Dietary ; Cell Proliferation ; Mammals

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 31.

Tytuł:

Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy.

Autorzy:

He J; Xiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China. .; Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, 410008, China. .; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, 410008, Huan, China. .; Hunan International Science and Technology Collaboration Base of Precision Medicine for Cancer, Changsha, 410008, China. .; Center for Molecular Imaging of Central, South University, Xiangya Hospital, Changsha, 410008, China. .
Zhou Y; Department of Pathology, Tongji Medical College Union Hospital, Huazhong University of Science and Technology, Wuhan, 430022, China.
Sun L; Xiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China. .; Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, 410008, China. .; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, 410008, Huan, China. .; Hunan International Science and Technology Collaboration Base of Precision Medicine for Cancer, Changsha, 410008, China. .; Center for Molecular Imaging of Central, South University, Xiangya Hospital, Changsha, 410008, China. .

Pokaż więcej

Źródło:

Cell communication and signaling : CCS [Cell Commun Signal] 2024 Jan 31; Vol. 22 (1), pp. 89. Date of Electronic Publication: 2024 Jan 31.

Typ publikacji:

Video-Audio Media; Journal Article; Review; Research Support, Non-U.S. Gov't

MeSH Terms:

Drug Resistance, Neoplasm*
Neoplasms*/drug therapy
Neoplasms*/pathology
Humans ; Unfolded Protein Response ; Endoplasmic Reticulum Stress ; Immunotherapy ; Tumor Microenvironment

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 32.

Tytuł:

Health system barriers to the implementation of the national action plan to combat antimicrobial resistance in Vietnam: a scoping review.

Autorzy:

Pham GN; Administration of Science Technology and Training, Ministry of Health, Hanoi, Vietnam.
Dang TTH; Woolcock Institute of Medical Research, Hanoi, Vietnam.
Nguyen TA; Woolcock Institute of Medical Research, Hanoi, Vietnam.; School of Public Health, The University of Sydney, Sydney, Australia.
Zawahir S; Woolcock Institute of Medical Research, Hanoi, Vietnam.; Central Clinical School, The University of Sydney, 90-92 Parramatta Road, Sydney, NSW, 2006, Australia.
Le HTT; Woolcock Institute of Medical Research, Hanoi, Vietnam.
Negin J; School of Public Health, The University of Sydney, Sydney, Australia.
Schneider CH; School of Public Health, The University of Sydney, Sydney, Australia.
Fox GJ; Woolcock Institute of Medical Research, Hanoi, Vietnam. .; Central Clinical School, The University of Sydney, 90-92 Parramatta Road, Sydney, NSW, 2006, Australia. .

Pokaż więcej

Źródło:

Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2024 Jan 25; Vol. 13 (1), pp. 12. Date of Electronic Publication: 2024 Jan 25.

Typ publikacji:

Journal Article; Review; Research Support, Non-U.S. Gov't

MeSH Terms:

Anti-Bacterial Agents*/therapeutic use
Drug Resistance, Bacterial*
Humans ; Vietnam ; Health Personnel ; Pharmacists

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 33.

Tytuł:

Cross-border differences in the prevalence and risk factors for carriage of antimicrobial resistance in children attending daycare centers: a point prevalence study in the Netherlands and Belgium.

Autorzy:

Dequeker S; Department of Epidemiology and public health, Sciensano, Brussels, Belgium. .; Agency for Care and Health, Infection Prevention and Control, Government of Flanders, Brussels, Belgium. .
van Hensbergen M; Department of Sexual Health, Infectious Diseases and Environmental Health, Living Lab Public Health, South Limburg Public Health Service, Heerlen, The Netherlands.; Department of Social Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, PO Box 616, 6200, MD, Maastricht, The Netherlands.
den Heijer CDJ; Department of Sexual Health, Infectious Diseases and Environmental Health, Living Lab Public Health, South Limburg Public Health Service, Heerlen, The Netherlands.; Department of Social Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, PO Box 616, 6200, MD, Maastricht, The Netherlands.
Dhaeze W; Agency for Care and Health, Infection Prevention and Control, Government of Flanders, Brussels, Belgium.
Raven SFH; Department of Infectious Diseases, Public Health Service region Utrecht, Zeist, The Netherlands.
Ewalts-Hakkoer H; Public Health Service Hart voor Brabant, Tilburg, The Netherlands.
Tolsma P; Public Health Service Brabant-Zuidoost, Eindhoven, The Netherlands.
Willemsen I; Contrain Infectiepreventiecoach, Breda, The Netherlands.; Amphia Hospital, Breda, The Netherlands.
van Drunen-Kamp KJ; Public Health Service Hart voor Brabant, Tilburg, The Netherlands.
van der Slikke-Verstraten K; Publich Health Service Zeeland, Goes, The Netherlands.
Goossens H; University of Antwerp, Antwerp, Belgium.
Kluytmans-van den Bergh MFQ; Amphia Hospital, Breda, The Netherlands.; UMC Utrecht, Utrecht, the Netherlands.
Hoebe CJPA; Department of Sexual Health, Infectious Diseases and Environmental Health, Living Lab Public Health, South Limburg Public Health Service, Heerlen, The Netherlands.; Department of Social Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, PO Box 616, 6200, MD, Maastricht, The Netherlands.; Department of Medical Microbiology, Infectious Diseases and Infection Prevention, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Centre (MUMC+), PO Box 5800, 6202, AZ, Maastricht, The Netherlands.

Pokaż więcej

Corporate Authors:

i-4-1-Health Study Group

Źródło:

BMC infectious diseases [BMC Infect Dis] 2024 Jan 24; Vol. 24 (1), pp. 131. Date of Electronic Publication: 2024 Jan 24.

Typ publikacji:

Journal Article

MeSH Terms:

Anti-Bacterial Agents*/pharmacology
Drug Resistance, Bacterial*
Child ; Humans ; Belgium/epidemiology ; Netherlands/epidemiology ; Prevalence ; Cross-Sectional Studies ; Risk Factors ; Ciprofloxacin

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 34.

Tytuł:

Modeling the limits of detection for antimicrobial resistance genes in agri-food samples: a comparative analysis of bioinformatics tools.

Autorzy:

Cooper AL; Research and Development, Ottawa Laboratory (Carling), Canadian Food Inspection Agency, Ottawa, ON, Canada.; Department of Biology, Carleton University, Ottawa, ON, Canada.
Low A; Research and Development, Ottawa Laboratory (Carling), Canadian Food Inspection Agency, Ottawa, ON, Canada.
Wong A; Department of Biology, Carleton University, Ottawa, ON, Canada.
Tamber S; Microbiology Research Division, Bureau of Microbial Hazards, Health Canada, Ottawa, ON, Canada.
Blais BW; Research and Development, Ottawa Laboratory (Carling), Canadian Food Inspection Agency, Ottawa, ON, Canada.; Department of Biology, Carleton University, Ottawa, ON, Canada.
Carrillo CD; Research and Development, Ottawa Laboratory (Carling), Canadian Food Inspection Agency, Ottawa, ON, Canada. .; Department of Biology, Carleton University, Ottawa, ON, Canada. .

Pokaż więcej

Źródło:

BMC microbiology [BMC Microbiol] 2024 Jan 20; Vol. 24 (1), pp. 31. Date of Electronic Publication: 2024 Jan 20.

Typ publikacji:

Journal Article

MeSH Terms:

Anti-Bacterial Agents*/pharmacology
Drug Resistance, Bacterial*/genetics
Animals ; Cattle ; Limit of Detection ; Bacteria/genetics ; Genes, Bacterial/genetics ; Metagenome ; Metagenomics/methods ; Computational Biology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 35.

Tytuł:

Exploring community insights on antimicrobial resistance in Nepal: a formative qualitative study.

Autorzy:

Parajuli A; HERD International, Bhaisepati, Lalitpur, Nepal. .
Garbovan L; Centre for World Cinema and Digital Cultures, University of Leeds, Woodhouse Lane, Leeds, LS2 9JT, UK.
Bhattarai B; HERD International, Bhaisepati, Lalitpur, Nepal.
Arjyal A; HERD International, Bhaisepati, Lalitpur, Nepal.
Baral S; HERD International, Bhaisepati, Lalitpur, Nepal.
Cooke P; Centre for World Cinema and Digital Cultures, University of Leeds, Woodhouse Lane, Leeds, LS2 9JT, UK.
Latham S; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Chester High Road, Neston, Liverpool, CH64 7TE, UK.
Barrington DJ; School of Population and Global Health, University of Western Australia, 35 Stirling Highway, Crawley, Perth, Western, 6009, Australia.
Mitchell J; Nuffield Centre for International Health and Development, University of Leeds, Woodhouse Lane, Leeds, LS2 9JT, UK.
King R; Nuffield Centre for International Health and Development, University of Leeds, Woodhouse Lane, Leeds, LS2 9JT, UK.

Pokaż więcej

Źródło:

BMC health services research [BMC Health Serv Res] 2024 Jan 11; Vol. 24 (1), pp. 57. Date of Electronic Publication: 2024 Jan 11.

Typ publikacji:

Journal Article

MeSH Terms:

Anti-Bacterial Agents*/pharmacology
Anti-Bacterial Agents*/therapeutic use
Drug Resistance, Bacterial*
Animals ; Humans ; Nepal ; Qualitative Research ; Research Design

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 36.

Tytuł:

On-site evaluation as external quality assessment of microbiology laboratories involved in sentinel laboratory-based antimicrobial resistance surveillance network in Burkina Faso.

Autorzy:

Zongo E; Higher Institute of Health Sciences, Nazi BONI University, Bobo-Dioulasso, Burkina Faso. .; National Reference Laboratory for Antimicrobial Resistance, Souro SANOU University Hospital Center, Bobo-Dioulasso, Burkina Faso. .; Laboratory of Emerging and Re-emerging Pathogens (LaPathER), Doctoral School of Health Sciences, Nazi BONI University, Bobo-Dioulasso, Burkina Faso. .; Health Sciences Research Institute, Ouagadougou, Burkina Faso. .
Dama E; US Centers for Disease Control and Prevention, Ouagadougou, Burkina Faso.
Yenyetou D; Higher Institute of Health Sciences, Nazi BONI University, Bobo-Dioulasso, Burkina Faso.; National Reference Laboratory for Antimicrobial Resistance, Souro SANOU University Hospital Center, Bobo-Dioulasso, Burkina Faso.; Laboratory of Emerging and Re-emerging Pathogens (LaPathER), Doctoral School of Health Sciences, Nazi BONI University, Bobo-Dioulasso, Burkina Faso.
Muhigwa M; Higher Institute of Health Sciences, Nazi BONI University, Bobo-Dioulasso, Burkina Faso.; National Reference Laboratory for Antimicrobial Resistance, Souro SANOU University Hospital Center, Bobo-Dioulasso, Burkina Faso.; Laboratory of Emerging and Re-emerging Pathogens (LaPathER), Doctoral School of Health Sciences, Nazi BONI University, Bobo-Dioulasso, Burkina Faso.
Nikiema A; Integrated Quality Laboratory Services, Ouagadougou, Burkina Faso.
Dahourou GA; US Centers for Disease Control and Prevention, Ouagadougou, Burkina Faso.
Ouedraogo AS; Higher Institute of Health Sciences, Nazi BONI University, Bobo-Dioulasso, Burkina Faso.; National Reference Laboratory for Antimicrobial Resistance, Souro SANOU University Hospital Center, Bobo-Dioulasso, Burkina Faso.; Laboratory of Emerging and Re-emerging Pathogens (LaPathER), Doctoral School of Health Sciences, Nazi BONI University, Bobo-Dioulasso, Burkina Faso.; MURAZ Center, Bobo-Dioulasso, Burkina Faso.

Pokaż więcej

Źródło:

Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2024 Jan 08; Vol. 13 (1), pp. 3. Date of Electronic Publication: 2024 Jan 08.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Anti-Bacterial Agents*/pharmacology
Drug Resistance, Bacterial*
Humans ; Burkina Faso ; Cross-Sectional Studies ; Laboratories

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 37.

Tytuł:

ULK2 Is a Key Pro-Autophagy Protein That Contributes to the High Chemoresistance and Disease Relapse in FLT3-Mutated Acute Myeloid Leukemia.

Autorzy:

Lai J; Department of Medicine, Division of Hematology, University of Alberta, Edmonton, AB T6G 2R3, Canada.
Yang C; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 2R3, Canada.
Shang C; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 2R3, Canada.
Chen W; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 2R3, Canada.
Chu MP; Department of Medicine, Division of Hematology, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Department of Medical Oncology, Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada.
Brandwein J; Department of Medicine, Division of Hematology, University of Alberta, Edmonton, AB T6G 2R3, Canada.
Lai R; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Department of Medical Oncology, Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada.
Wang P; Department of Medicine, Division of Hematology, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Department of Medical Oncology, Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2024 Jan 04; Vol. 25 (1). Date of Electronic Publication: 2024 Jan 04.

Typ publikacji:

Journal Article

MeSH Terms:

Drug Resistance, Neoplasm*/genetics
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/genetics
Protein Serine-Threonine Kinases*/genetics
Humans ; Autophagy/genetics ; Biological Assay ; Chronic Disease ; Cytarabine/pharmacology ; fms-Like Tyrosine Kinase 3/genetics

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 38.

Tytuł:

High-expressed ACAT2 predicted the poor prognosis of platinum-resistant epithelial ovarian cancer.

Autorzy:

Wang J; Department of Obstetrics and Gynecology, First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, Shaanxi, 710061, China.
Yang Z; Department of Pathology, First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, Shaanxi, 710061, China.
Bai H; The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Western China Science and Technology Innovation Harbor, Building 21, Xi'an, 710000, China.
Zhao L; Department of Obstetrics and Gynecology, First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, Shaanxi, 710061, China.
Ji J; Department of Obstetrics and Gynecology, First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, Shaanxi, 710061, China.
Bin Y; Department of Obstetrics and Gynecology, First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, Shaanxi, 710061, China.
Liu Y; Department of Pathology, First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, Shaanxi, 710061, China.
Zhang S; Department of Obstetrics and Gynecology, First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, Shaanxi, 710061, China.
Hou H; Department of Pathology, First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, Shaanxi, 710061, China. .
Li Q; Department of Obstetrics and Gynecology, First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, Shaanxi, 710061, China. .

Pokaż więcej

Źródło:

Diagnostic pathology [Diagn Pathol] 2024 Jan 04; Vol. 19 (1), pp. 7. Date of Electronic Publication: 2024 Jan 04.

Typ publikacji:

Journal Article

MeSH Terms:

Ovarian Neoplasms*/pathology
Drug Resistance, Neoplasm*
Female ; Humans ; Acetyltransferases ; Carcinoma, Ovarian Epithelial/pathology ; Cell Line, Tumor ; Prognosis

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 39.

Tytuł:

Environmental aspects of antimicrobial resistance in India: Current progress & way forward.

Autorzy:

Bhatia R; Former Director, Communicable Diseases, WHO Regional Office for South-East Asia, New Delhi 110 002, India .

Pokaż więcej

Źródło:

The Indian journal of medical research [Indian J Med Res] 2024 Jan 01; Vol. 159 (1), pp. 10-15. Date of Electronic Publication: 2024 Mar 04.

Typ publikacji:

Journal Article

MeSH Terms:

Anti-Bacterial Agents*/therapeutic use
Drug Resistance, Bacterial*/genetics
Humans ; India/epidemiology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 40.

Tytuł:

Prediction of Chemoresistance-How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer.

Autorzy:

Wilczyński J; Department of Gynecological Surgery and Gynecological Oncology, Medical University of Lodz, 4 Kosciuszki Str., 90-419 Lodz, Poland.
Paradowska E; Laboratory of Virology, Institute of Medical Biology of the Polish Academy of Sciences, 106 Lodowa Str., 93-232 Lodz, Poland.
Wilczyńska J; Department of Tele-Radiotherapy, Mikolaj Kopernik Provincial Multi-Specialized Oncology and Traumatology Center, 62 Pabianicka Str., 93-513 Lodz, Poland.
Wilczyński M; Department of Gynecological, Endoscopic and Oncological Surgery, Polish Mother's Health Center-Research Institute, 281/289 Rzgowska Str., 93-338 Lodz, Poland.; Department of Surgical and Endoscopic Gynecology, Medical University of Lodz, 4 Kosciuszki Str., 90-419 Lodz, Poland.

Pokaż więcej

Źródło:

Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Dec 29; Vol. 31 (1), pp. 229-249. Date of Electronic Publication: 2023 Dec 29.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Drug Resistance, Neoplasm*
Ovarian Neoplasms*/drug therapy
Humans ; Female ; Epigenesis, Genetic ; Neoplasm Recurrence, Local ; Biomarkers ; Tumor Microenvironment

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 41.

Tytuł:

Prevalence and antibiotics resistance status of Salmonella in raw meat consumed in various areas of Lahore, Pakistan.

Autorzy:

Fatima A; Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore, 54590, Pakistan.
Saleem M; Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore, 54590, Pakistan.
Nawaz S; Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore, 54590, Pakistan.
Khalid L; Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore, 54590, Pakistan.
Riaz S; Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore, 54590, Pakistan.
Sajid I; Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore, 54590, Pakistan. .

Pokaż więcej

Źródło:

Scientific reports [Sci Rep] 2023 Dec 14; Vol. 13 (1), pp. 22205. Date of Electronic Publication: 2023 Dec 14.

Typ publikacji:

Journal Article

MeSH Terms:

Drug Resistance, Multiple, Bacterial*/genetics
Salmonella enterica*/genetics
Animals ; Female ; Cattle ; Prevalence ; Pakistan/epidemiology ; RNA, Ribosomal, 16S ; Microbial Sensitivity Tests ; Salmonella/genetics ; Meat ; Anti-Bacterial Agents/pharmacology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 42.

Tytuł:

IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer.

Autorzy:

Li XH; Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfengdong Road, Guangzhou, 510060, China.
Huang GZ; Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfengdong Road, Guangzhou, 510060, China.
Xu ZL; Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfengdong Road, Guangzhou, 510060, China.
Zhao CY; Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Dong XY; Department of Gynecology, Guangdong Hydropower Hospital, Guangzhou, 510060, China.
Cui BK; Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfengdong Road, Guangzhou, 510060, China.
Lin XJ; Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfengdong Road, Guangzhou, 510060, China. .

Pokaż więcej

Źródło:

Journal of translational medicine [J Transl Med] 2023 Dec 14; Vol. 21 (1), pp. 911. Date of Electronic Publication: 2023 Dec 14.

Typ publikacji:

Journal Article

MeSH Terms:

Drug Resistance, Neoplasm*
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/metabolism
Humans ; Cell Line, Tumor ; Signal Transduction ; Prognosis ; Neoplastic Stem Cells/pathology ; Tumor Microenvironment

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 43.

Tytuł:

Sorafenib regulates c-CBL gene-mediated chemoresistance in acute myeloid leukemia cells.

Autorzy:

Sun Q; Department of Geriatric Hematology and Oncology, Guangzhou First People's Hospital, Guangzhou, China.
Wu B; Department of Hematology and Oncology, Cancer Center of Sun Yat-sen University, Guangzhou, China.; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
Meng F; Department of Hematology, Kanghua Hospital, Dongguan, China.
Yao Q; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
Huang Z; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
Xu J; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
Zhu Z; Department of Geriatric Hematology and Oncology, Guangzhou First People's Hospital, Guangzhou, China.

Pokaż więcej

Źródło:

Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2204620.

Typ publikacji:

Journal Article

MeSH Terms:

Drug Resistance, Neoplasm*/genetics
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/genetics
Sorafenib*/pharmacology
Sorafenib*/therapeutic use
Humans ; Apoptosis ; fms-Like Tyrosine Kinase 3/genetics ; Mutation ; Proto-Oncogene Proteins c-cbl/genetics ; Receptor Protein-Tyrosine Kinases/genetics

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 44.

Tytuł:

Unveiling the mechanism of action of acylated temporin L analogues against multidrug-resistant Candida albicans .

Autorzy:

Bellavita R; Department of Pharmacy, University of Naples 'Federico II', Naples, Italy.
Falanga A; Department of Agricultural Science, University of Naples 'Federico II', Portici, Italy.
Merlino F; Department of Pharmacy, University of Naples 'Federico II', Naples, Italy.
D'Auria G; Department of Pharmacy, University of Naples 'Federico II', Naples, Italy.
Molfetta N; Department of Pharmacy, University of Naples 'Federico II', Naples, Italy.
Saviano A; Department of Pharmacy, University of Naples 'Federico II', Naples, Italy.
Maione F; Department of Pharmacy, University of Naples 'Federico II', Naples, Italy.
Galdiero U; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Catania MR; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Galdiero S; Department of Pharmacy, University of Naples 'Federico II', Naples, Italy.
Grieco P; Department of Pharmacy, University of Naples 'Federico II', Naples, Italy.
Roscetto E; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Falcigno L; Department of Pharmacy, University of Naples 'Federico II', Naples, Italy.
Buommino E; Department of Pharmacy, University of Naples 'Federico II', Naples, Italy.

Pokaż więcej

Źródło:

Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2023 Dec; Vol. 38 (1), pp. 36-50.

Typ publikacji:

Journal Article

MeSH Terms:

Antifungal Agents*/pharmacology
Candida albicans*/drug effects
Drug Resistance, Multiple, Fungal*
Humans ; Antimicrobial Cationic Peptides/pharmacology ; Microbial Sensitivity Tests ; Voriconazole/pharmacology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 45.

Tytuł:

Advance in Targeted Cancer Therapy and Mechanisms of Resistance.

Autorzy:

Tang PM; State Key Laboratory of Translational Oncology, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
Zhang D; College of Pharmacy, Jinan University, Guangzhou 510632, China.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 Nov 22; Vol. 24 (23). Date of Electronic Publication: 2023 Nov 22.

Typ publikacji:

Editorial

MeSH Terms:

Drug Resistance, Neoplasm*
Neoplasms*/drug therapy
Humans

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 46.

Tytuł:

Association between quality of governance, antibiotic consumption, and antimicrobial resistance: an analysis of Italian regions.

Autorzy:

Maugeri A; Department of Medical and Surgical Sciences and Advanced Technologies 'GF Ingrassia', University of Catania, Via S. Sofia 87, 95123, Catania, Italy.
Barchitta M; Department of Medical and Surgical Sciences and Advanced Technologies 'GF Ingrassia', University of Catania, Via S. Sofia 87, 95123, Catania, Italy.
Agodi A; Department of Medical and Surgical Sciences and Advanced Technologies 'GF Ingrassia', University of Catania, Via S. Sofia 87, 95123, Catania, Italy. .

Pokaż więcej

Źródło:

Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2023 Nov 21; Vol. 12 (1), pp. 130. Date of Electronic Publication: 2023 Nov 21.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Anti-Bacterial Agents*/therapeutic use
Anti-Bacterial Agents*/pharmacology
Drug Resistance, Bacterial*
Humans ; Italy ; Policy ; Government

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 47.

Tytuł:

Strain of Multidrug-Resistant Salmonella Newport Remains Linked to Travel to Mexico and U.S. Beef Products - United States, 2021-2022.

Autorzy:

Ford L
Ellison Z
Schwensohn C
Griffin I
Birhane MG
Cote A
Fortenberry GZ
Tecle S
Higa J
Spencer S
Patton B
Patel J
Dow J
Maroufi A
Robbins A
Donovan D
Fitzgerald C
Burrell S
Tolar B
Folster JP
Cooley LA
Francois Watkins LK

Pokaż więcej

Źródło:

MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2023 Nov 10; Vol. 72 (45), pp. 1225-1229. Date of Electronic Publication: 2023 Nov 10.

Typ publikacji:

Journal Article

MeSH Terms:

Drug Resistance, Multiple, Bacterial*
Salmonella enterica*
United States/epidemiology ; Humans ; Cattle ; Animals ; Sheep ; Mexico/epidemiology ; Salmonella ; District of Columbia

SCR Organism:

Salmonella enterica subsp. enterica

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 48.

Tytuł:

Efficient Synthesis of Acylated, Dialkyl α-Hydroxy-Benzylphosphonates and Their Anticancer Activity.

Autorzy:

Varga PR; Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, 1521 Budapest, Hungary.
Belovics A; Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, 1521 Budapest, Hungary.
Bagi P; Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, 1521 Budapest, Hungary.
Tóth S; Research Centre for Natural Sciences, Institute of Enzymology, 1117 Budapest, Hungary.
Szakács G; Research Centre for Natural Sciences, Institute of Enzymology, 1117 Budapest, Hungary.; Institute of Cancer Research, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria.
Bősze S; Eötvös Loránd Research Network (ELKH), Research Group of Peptide Chemistry, Eötvös Loránd University, 1117 Budapest, Hungary.
Szabó R; Eötvös Loránd Research Network (ELKH), Research Group of Peptide Chemistry, Eötvös Loránd University, 1117 Budapest, Hungary.
Drahos L; Research Centre for Natural Sciences, MS Proteomics Research Group, 1117 Budapest, Hungary.
Keglevich G; Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, 1521 Budapest, Hungary.

Pokaż więcej

Źródło:

Molecules (Basel, Switzerland) [Molecules] 2022 Mar 23; Vol. 27 (7). Date of Electronic Publication: 2022 Mar 23.

Typ publikacji:

Journal Article

MeSH Terms:

Antineoplastic Agents*
Drug Resistance, Multiple*
Cell Line, Tumor ; Drug Resistance, Neoplasm ; Drug Screening Assays, Antitumor ; Stereoisomerism ; Structure-Activity Relationship

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 49.

Tytuł:

Equal rates of drug resistance in leprosy cases with relapse and recurrent/chronic Type 2 reaction: time to revise the guidelines for drug-resistance testing in leprosy?

Autorzy:

Narang T; Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Kamat D; Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Thakur V; Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Lavania M; Enteric Viruses Group, ICMR-National Institute of Virology, Pune, India.
Singh I; Department of Molecular Biology, Stanley Browne Laboratory, TLM Community Hospital, New Delhi, India.
Ahuja M; Department of Molecular Biology, Stanley Browne Laboratory, TLM Community Hospital, New Delhi, India.
Dogra S; Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Pokaż więcej

Źródło:

Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Feb; Vol. 47 (2), pp. 297-302. Date of Electronic Publication: 2021 Sep 24.

Typ publikacji:

Journal Article; Observational Study

MeSH Terms:

Drug Resistance, Bacterial*/genetics
Leprostatic Agents/*therapeutic use
Leprosy/*drug therapy
Mycobacterium leprae/*drug effects
Adult ; Chronic Disease ; Cross-Sectional Studies ; Drug Resistance, Multiple, Bacterial ; Endemic Diseases ; Female ; Humans ; Male ; Middle Aged ; Recurrence

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 50.

Tytuł:

Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies.

Autorzy:

Catalano A; Department of Pharmacy-Drug Sciences, University of Bari 'Aldo Moro', 70126 Bari, Italy.
Iacopetta D; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, Italy.
Ceramella J; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, Italy.
Scumaci D; Research Center on Advanced Biochemistry and Molecular Biology, Department of Experimental and Clinical Medicine, Magna Græcia University of Catanzaro, 88100 Catanzaro, Italy.
Giuzio F; International PhD Programme 'Sciences', Department of Science, University of Basilicata, Viale dell'Ateneo Lucano n. 10, 85100 Potenza, Italy.
Saturnino C; Department of Science, University of Basilicata, 85100 Potenza, Italy.
Aquaro S; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, Italy.
Rosano C; Proteomics and Mass Spectrometry Unit, IRCCS Policlinico San Martino, Largo Rosanna Benzi, 10, 16132 Genoa, Italy.
Sinicropi MS; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Arcavacata di Rende, Italy.

Pokaż więcej

Źródło:

Molecules (Basel, Switzerland) [Molecules] 2022 Jan 18; Vol. 27 (3). Date of Electronic Publication: 2022 Jan 18.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Drug Resistance, Multiple*
Drug Resistance, Neoplasm*
Animals ; Drug Resistance, Microbial ; Humans ; Nanoparticle Drug Delivery System

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły